You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Completed
      Has Results
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +23 more
      • Denver, Colorado
      • +2 more
      Jun 17, 2021

      Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

      Not yet recruiting
      • Chronic Myelogenous Leukemia
      • Houston, Texas
        The University of Texas MD Anderson Cancer Center
      Oct 12, 2023

      Biology of Long-Term Late Effects Following Hematopoietic Cell

      Active, not recruiting
      • Acute Lymphoblastic Leukemia/Lymphoma
      • +4 more
        • Scottsdale, Arizona
        • +31 more
        Mar 8, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

        Recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 31, 2022

        Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Dasatinib Pill
        • Ketoconazole Pill
        • Monterrey, Nuevo Leon, Mexico
          Hospital Universitario Dr. José Eleuterio González
        Nov 25, 2022

        Blastic Phase, Childhood Acute Promyelocytic Leukemia With PML-RARA, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive

        Completed
        Has Results
        • Blastic Phase
        • +9 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Birmingham, Alabama
        • +24 more
        Jan 13, 2021

        Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

        Active, not recruiting
        • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 2, 2022

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 24, 2022

        Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

        Recruiting
        • Chronic Myeloid Leukemia in Myeloid Blast Crisis
        • +3 more
        • based decitabine and olverembatinib（HQP1351)chemotherapy
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Dec 6, 2022

        Asciminib RMP Study

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Jul 5, 2023

        Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

        Recruiting
        • Chronic Myelogenous Leukemia
        • Beijing, Beijing, China
          Peking University People's Hospital
        Jun 27, 2022

        Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

        Not yet recruiting
        • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
        • (no location specified)
        Jun 7, 2022

        Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

        Completed
        • Hematopoietic/Lymphoid Cancer
        • +135 more
        • beclomethasone dipropionate
        • +4 more
        • Hackensack, New Jersey
        • +1 more
        Feb 1, 2021

        Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

        Completed
        • Chronic Myeloid Leukemia
          • East Hanover, New Jersey
            Novartis
          Nov 20, 2023

          Chronic Myeloid Leukemia Trial in France (biological samples)

          Completed
          • Chronic Myeloid Leukemia
          • biological samples
          • Belfort, France
          • +3 more
          May 31, 2022

          Ponatinib in CML Patients in Chronic Phase

          Recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
          • Therapeutic drug monitoring
          • Molecular Response
          • Cagliari, Italy
          • +4 more
          Nov 3, 2023

          Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

          Active, not recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Jena, Germany
              University Hospital Jena
            Jan 17, 2023

            Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

            Recruiting
            • Chronic Phase Chronic Myelogenous Leukemia
            • +3 more
            • Houston, Texas
              M D Anderson Cancer Center
            Aug 11, 2022

            Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

            Recruiting
            • Chronic Myelogenous Leukemia - Chronic Phase
            • Birmingham, Alabama
            • +25 more
            Jan 10, 2023

            Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

            Recruiting
            • Leukemia, Chronic Myelogenous
            • Chongqing City, Chongqing, China
            • +23 more
            Jan 18, 2023

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023